e of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Chicago, Germany, Tula, Russia, California, New York, New Jersey, North Carolina, Tennessee, Massachusetts and Georgia.
About eResearchTechnology, Inc. (ERT)
Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) (http://www.ert.com) is a provider of cardiac safety and ePRO technology and services to the global biopharmaceutical and medical device industries. The Company is the market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development.
Safe Harbor Disclaimer
Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ
'/>"/>
SOURCE OmniComm Systems, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific2.
OmniComm Systems Announces 1st Quarter Results of Operations3.
OmniComm Systems Announces Settlement of Patent Litigation With DataSci, LLC4.
OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 20085.
OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services6.
MicroFluidic Systems (MFSI) Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis.7.
A-Power Energy Generation Systems Ltd. Signs a Biomass-Based DG Contract with Sanmenxia New Energy Bio-Electricity Co., Ltd.8.
Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index9.
Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems10.
Delcath Systems Granted Third Orphan Drug Designation11.
Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare